Pierre Sujobert

2.5k total citations · 1 hit paper
40 papers, 612 citations indexed

About

Pierre Sujobert is a scholar working on Pathology and Forensic Medicine, Genetics and Hematology. According to data from OpenAlex, Pierre Sujobert has authored 40 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 15 papers in Genetics and 11 papers in Hematology. Recurrent topics in Pierre Sujobert's work include Lymphoma Diagnosis and Treatment (17 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Acute Myeloid Leukemia Research (8 papers). Pierre Sujobert is often cited by papers focused on Lymphoma Diagnosis and Treatment (17 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Acute Myeloid Leukemia Research (8 papers). Pierre Sujobert collaborates with scholars based in France, United States and Switzerland. Pierre Sujobert's co-authors include Gilles Salles, Sarah Huet, Estelle Bourbon, Yvan Jamilloux, Thomas Barba, Cécile‐Audrey Durel, Maël Heiblig, P. Sève, Fiorenza Barraco and Jean‐Christophe Lega and has published in prestigious journals such as Nature Communications, Nature reviews. Cancer and Blood.

In The Last Decade

Pierre Sujobert

36 papers receiving 605 citations

Hit Papers

Therapeutic options in VE... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Sujobert France 12 247 238 229 196 121 40 612
Guiyuan Lei United Kingdom 12 480 1.9× 175 0.7× 509 2.2× 343 1.8× 228 1.9× 28 891
Emanuela Carlotti United Kingdom 10 164 0.7× 67 0.3× 326 1.4× 230 1.2× 171 1.4× 20 579
Alina Dulau‐Florea United States 14 293 1.2× 224 0.9× 83 0.4× 101 0.5× 121 1.0× 29 624
Claire Dearden United Kingdom 9 531 2.1× 273 1.1× 369 1.6× 197 1.0× 160 1.3× 16 947
Leonardo Boiocchi United States 16 299 1.2× 127 0.5× 73 0.3× 69 0.4× 113 0.9× 29 610
Kyle Perry United States 10 106 0.4× 119 0.5× 336 1.5× 252 1.3× 45 0.4× 29 603
Julia Steinhilber Germany 15 235 1.0× 32 0.1× 392 1.7× 260 1.3× 132 1.1× 28 652
Marjan Daneshpouy France 9 54 0.2× 71 0.3× 172 0.8× 117 0.6× 196 1.6× 12 505
Annette M. May Germany 14 109 0.4× 77 0.3× 52 0.2× 131 0.7× 125 1.0× 35 559
Atsushi Notoya Japan 11 92 0.4× 68 0.3× 170 0.7× 131 0.7× 187 1.5× 28 484

Countries citing papers authored by Pierre Sujobert

Since Specialization
Citations

This map shows the geographic impact of Pierre Sujobert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Sujobert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Sujobert more than expected).

Fields of papers citing papers by Pierre Sujobert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Sujobert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Sujobert. The network helps show where Pierre Sujobert may publish in the future.

Co-authorship network of co-authors of Pierre Sujobert

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Sujobert. A scholar is included among the top collaborators of Pierre Sujobert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Sujobert. Pierre Sujobert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steffens, A.B., et al.. (2025). Epstein–Barr virus induces aberrant B cell migration and diapedesis via FAK-dependent chemotaxis pathways. Nature Communications. 16(1). 4581–4581.
2.
Chin‐Yee, Benjamin, Lucie Laplane, & Pierre Sujobert. (2025). Epistemic limitations of measurable residual disease in haematological malignancies. The Lancet Haematology. 12(3). e224–e229.
3.
Verney, Aurélie, Jérôme Guitton, Alexandra Traverse‐Glehen, et al.. (2024). Functional precision oncology for follicular lymphoma with patient-derived xenograft in avian embryos. Leukemia. 38(2). 430–434. 2 indexed citations
4.
Bourbon, Estelle, Kaddour Chabane, Isabelle Mosnier, et al.. (2023). Next-CLL, a New Next-Generation Sequencing–Based Method for Assessment of IGHV Gene Mutational Status in Chronic Lymphoid Leukemia. Journal of Molecular Diagnostics. 25(5). 274–283. 2 indexed citations
5.
Billaud, Marc, Marie Castets, Alain Trautmann, & Pierre Sujobert. (2023). Cancers évitables. médecine/sciences. 39(5). 452–457.
6.
Pleșa, Adriana, Gaëlle Fossard, Fiorenza Barraco, et al.. (2022). Impact on Outcome of Minimal Residual Disease after Hematopoietic Stem Cell Transplantation with Fludarabine, Amsacrine, and Cytosine Arabinoside-Busulfan Conditioning: A Retrospective Monocentric Study. Transplantation and Cellular Therapy. 29(1). 38.e1–38.e9. 4 indexed citations
7.
Mauduit, Claire, Juliette Fontaine, Estelle Bourbon, et al.. (2021). Real‐life targeted next‐generation sequencing for lymphoma diagnosis over 1 year from the French Lymphoma Network. British Journal of Haematology. 193(6). 1110–1122. 8 indexed citations
8.
Hayette, Sandrine, Maxime Vallée, Claire Bardel, et al.. (2021). Performances of Targeted RNA Sequencing for the Analysis of Fusion Transcripts, Gene Mutation, and Expression in Hematological Malignancies. HemaSphere. 5(2). e522–e522. 5 indexed citations
9.
Pleșa, Adriana, Hélène Labussière‐Wallet, Sandrine Hayette, et al.. (2019). Efficiency of blinatumomab in a t(8;21) acute myeloid leukemia expressing CD19. Haematologica. 104(10). e487–e488. 5 indexed citations
10.
Pleșa, Adriana & Pierre Sujobert. (2019). Cannibalistic acute myeloid leukemia with ZMYND11-MBTD1 fusion. Blood. 133(16). 1789–1789. 8 indexed citations
11.
Étienne, Gabriel, Stéphanie Dulucq, Françoise Huguet, et al.. (2019). Incidence and outcome of BCR‐ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors. Cancer Medicine. 8(11). 5173–5182. 15 indexed citations
12.
Sujobert, Pierre & Gilles Salles. (2019). Actualités dans le lymphome folliculaire. La Presse Médicale. 48(7-8). 850–858. 1 indexed citations
13.
Callet‐Bauchu, Evelyne, et al.. (2017). Advances in the role of cytogenetic analysis in the molecular diagnosis of B-cell lymphomas. Expert Review of Molecular Diagnostics. 17(6). 623–632. 2 indexed citations
14.
Sujobert, Pierre, Isabelle Tigaud, Sandrine Hayette, et al.. (2017). Bone Marrow Necrosis in Newly Diagnosed Acute Leukemia: Two Case Reports and Review of the Literature. Oncology and Therapy. 5(1). 111–118. 8 indexed citations
15.
Sujobert, Pierre, Catherine Rioufol, & Gilles Salles. (2016). Idelalisib. The Cancer Journal. 22(1). 12–16. 2 indexed citations
16.
Sujobert, Pierre & Jérôme Tamburini. (2015). Co-activation of AMPK and mTORC1 as a new therapeutic option for acute myeloid leukemia. Molecular & Cellular Oncology. 3(4). e1071303–e1071303. 7 indexed citations
17.
Sujobert, Pierre, Clémentine Sarkozy, Alexandra Traverse‐Glehen, et al.. (2015). CD180 overexpression in follicular lymphoma is restricted to the lymph node compartment. Cytometry Part B Clinical Cytometry. 90(5). 433–439. 8 indexed citations
18.
Bisig, Bettina, Aurélien de Reyniès, Christophe Bonnet, et al.. (2013). CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features. Haematologica. 98(8). 1250–1258. 52 indexed citations
19.
Sujobert, Pierre, Nicolas Boissel, Anne Bergeron, et al.. (2010). Breakthrough zygomycosis following empirical caspofungin treatment: report of two patients with leukemia and literature review. 1(1). 3 indexed citations
20.
Sujobert, Pierre, Valérie Bardet, & Marie Bienvenu. (2007). Bilateral adrenal chloromas. British Journal of Haematology. 140(3). 254–254. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026